Episurf Medical (Nasdaq: EPIS B), a pioneer and leader in individualised technologies for painful joint injuries, today announces that the Episealer® knee implants have been registered and approved for sale in Italy. The company is also in the final stages of establishing distribution in the Lombardia region as a first step.
“We have identified the Italian market as an attractive market, and we have now completed a local regulatory registration process. We have attended industry congresses in Italy, and had Italian visitors at our masterclass in Stockholm in June. There is a genuine